Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Department of Physical Therapy, Faculty of Medical Science, Fukuoka International University of Health and Welfare, Fukuoka, Japan.
BMJ Open. 2023 Aug 7;13(8):e074007. doi: 10.1136/bmjopen-2023-074007.
We aimed to clarify the relationship between serum alanine transaminase (ALT) levels and incidence of new-onset diabetes in a Japanese general population.
Population-based retrospective cohort study using annual health check-up data for residents of Iki City, Nagasaki Prefecture, Japan.
A total of 5330 Japanese individuals (≥30 years old) without diabetes at baseline were analysed.
Serum ALT levels were determined using an enzymatic method and were classified into gender-specific quartile groups as follows: group 1 (3-16 U/L in men and 3-13 U/L in women), group 2 (17-21 U/L in men and 14-16 U/L in women), group 3 (22-29 U/L in men and 17-22 U/L in women) and group 4 (30-428 U/L in men and 23-268 U/L in women). The study outcome was the incidence of diabetes (fasting glucose ≥7.0 mmol/L, non-fasting glucose ≥11.1 mmol/L, glycated haemoglobin ≥6.5% or use of glucose-lowering therapies).
After an average follow-up period of 5.0 years, 279 individuals developed diabetes. The incidence rate of diabetes increased with elevation of serum ALT levels (0.7% per 100 person-years in group 1, 0.9% in group 2, 0.9% in group 3 and 1.7% in group 4) (p<0.001 for trend). This association was significant after adjustment for other risk factors including age, sex, obesity, hypertension, dyslipidaemia, smoking, current daily alcohol intake and regular exercise (p<0.001 for trend). Comparable associations were observed between men and women (p=0.459 for interaction).
Serum ALT levels were associated with future development of diabetes in the general Japanese population.
我们旨在阐明日本一般人群中血清丙氨酸转氨酶(ALT)水平与新发糖尿病之间的关系。
使用日本长崎县壱岐市居民年度健康检查数据进行基于人群的回顾性队列研究。
共分析了 5330 名基线时无糖尿病的日本个体(≥30 岁)。
使用酶法测定血清 ALT 水平,并按性别分为特定四分位组:第 1 组(男性 3-16U/L,女性 3-13U/L),第 2 组(男性 17-21U/L,女性 14-16U/L),第 3 组(男性 22-29U/L,女性 17-22U/L)和第 4 组(男性 30-428U/L,女性 23-268U/L)。研究结果为糖尿病的发病率(空腹血糖≥7.0mmol/L,非空腹血糖≥11.1mmol/L,糖化血红蛋白≥6.5%或使用降糖治疗)。
在平均 5.0 年的随访期间,279 人发生了糖尿病。随着血清 ALT 水平的升高,糖尿病的发病率增加(第 1 组每 100 人年 0.7%,第 2 组 0.9%,第 3 组 0.9%,第 4 组 1.7%)(趋势 p<0.001)。在调整其他危险因素(包括年龄、性别、肥胖、高血压、血脂异常、吸烟、当前每日饮酒量和规律运动)后,这种关联仍然显著(趋势 p<0.001)。在男性和女性之间观察到类似的关联(交互作用 p=0.459)。
血清 ALT 水平与日本一般人群未来发生糖尿病有关。